BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23883624)

  • 1. Phospholipase C-γ2 via p38 and ERK1/2 MAP kinase mediates diperoxovanadate-asparagine induced human platelet aggregation and sCD40L release.
    Misra A; Srivastava S; Ankireddy SR; Islam NS; Chandra T; Kumar A; Barthwal MK; Dikshit M
    Redox Rep; 2013; 18(5):174-85. PubMed ID: 23883624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain.
    Kojok K; Mohsen M; El Kadiry AEH; Mourad W; Merhi Y
    J Am Heart Assoc; 2020 Feb; 9(3):e013396. PubMed ID: 32009527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane A(2) promotes soluble CD40 ligand release from human platelets.
    Enomoto Y; Adachi S; Matsushima-Nishiwaki R; Doi T; Niwa M; Akamatsu S; Tokuda H; Ogura S; Yoshimura S; Iwama T; Kozawa O
    Atherosclerosis; 2010 Apr; 209(2):415-21. PubMed ID: 19932480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac regulates collagen-induced HSP27 phosphorylation via p44/p42 MAP kinase in human platelets.
    Kageyama Y; Doi T; Akamatsu S; Kuroyanagi G; Kondo A; Mizutani J; Otsuka T; Tokuda H; Kozawa O; Ogura S
    Int J Mol Med; 2013 Oct; 32(4):813-8. PubMed ID: 23900529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protein tyrosine phosphatase PTPN7 is a negative regulator of ERK activation and thromboxane generation in platelets.
    Inamdar VV; Reddy H; Dangelmaier C; Kostyak JC; Kunapuli SP
    J Biol Chem; 2019 Aug; 294(33):12547-12554. PubMed ID: 31266805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Rac in thromboxane A2‑induced human platelet activation: regulation of sCD40 ligand release and PDGF‑AB secretion.
    Kageyama Y; Doi T; Matsushima-Nishiwaki R; Iida Y; Akamatsu S; Kondo A; Kuroyanagi G; Yamamoto N; Mizutani J; Otsuka T; Tokuda H; Iida H; Kozawa O; Ogura S
    Mol Med Rep; 2014 Jul; 10(1):107-12. PubMed ID: 24737161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of p38 MAP kinase in diperoxovanadate-induced phospholipase D activation in endothelial cells.
    Natarajan V; Scribner WM; Morris AJ; Roy S; Vepa S; Yang J; Wadgaonkar R; Reddy SP; Garcia JG; Parinandi NL
    Am J Physiol Lung Cell Mol Physiol; 2001 Aug; 281(2):L435-49. PubMed ID: 11435219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation.
    Lee YM; Chen WF; Chou DS; Jayakumar T; Hou SY; Lee JJ; Hsiao G; Sheu JR
    J Biomed Sci; 2010 Jun; 17(1):45. PubMed ID: 20525309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin eugenol ester inhibits agonist-induced platelet aggregation in vitro by regulating PI3K/Akt, MAPK and Sirt 1/CD40L pathways.
    Shen DS; Yang YJ; Kong XJ; Ma N; Liu XW; Li SH; Jiao ZH; Qin Z; Huang MZ; Li JY
    Eur J Pharmacol; 2019 Jun; 852():1-13. PubMed ID: 30797789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase.
    Iida Y; Doi T; Tokuda H; Matsushima-Nishiwaki R; Tsujimoto M; Kuroyanagi G; Yamamoto N; Enomoto Y; Tanabe K; Otsuka T; Iwama T; Ogura S; Kozawa O; Iida H
    Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():73-81. PubMed ID: 25500336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet action of indirubin-3'-monoxime through suppression of glycoprotein VI-mediated signal transduction: a possible role for ERK signaling in platelets.
    Lee JJ; Han JH; Jung SH; Lee SG; Kim IS; Cuong NM; Huong TT; Khanh PN; Kim YH; Yun YP; Ma JY; Myung CS
    Vascul Pharmacol; 2014 Dec; 63(3):182-92. PubMed ID: 25451564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac Regulates the TRAP-Induced Release of Phosphorylated-HSP27 from Human Platelets via p38 MAP Kinase but Not JNK.
    Uematsu K; Enomoto Y; Onuma T; Tsujimoto M; Doi T; Matsushima-Nishiwaki R; Tokuda H; Ogura S; Iida H; Kozawa O; Iwama T
    Cell Physiol Biochem; 2018; 49(4):1523-1538. PubMed ID: 30212812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of nuclear factor κB in platelet CD40 signaling.
    Hachem A; Yacoub D; Zaid Y; Mourad W; Merhi Y
    Biochem Biophys Res Commun; 2012 Aug; 425(1):58-63. PubMed ID: 22820189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta peptide-activated signal pathways in human platelets.
    Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY
    Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation.
    Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F
    Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade.
    Fälker K; Klarström-Engström K; Bengtsson T; Lindahl TL; Grenegård M
    Cell Signal; 2014 Feb; 26(2):279-86. PubMed ID: 24240055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets.
    Garcia A; Quinton TM; Dorsam RT; Kunapuli SP
    Blood; 2005 Nov; 106(10):3410-4. PubMed ID: 16020504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for PLCgamma2 in platelet activation by homocysteine.
    Leoncini G; Bruzzese D; Signorello MG
    J Cell Biochem; 2007 Apr; 100(5):1255-65. PubMed ID: 17063483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol-3,4,5-trisphosphate stimulates Ca(2+) elevation and Akt phosphorylation to constitute a major mechanism of thromboxane A2 formation in human platelets.
    Kassouf N; Ambily A; Watson S; Hassock S; Authi HS; Srivastava S; Watson SP; Authi KS
    Cell Signal; 2015 Jul; 27(7):1488-98. PubMed ID: 25797048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
    Kuliopulos A; Mohanlal R; Covic L
    Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.